. Mice lacking the dopamine transporter display altered regulation of distal colonic motility. Am J Physiol Gastrointest Liver Physiol 279: G311-G318, 2000.-The mechanisms by which dopamine (DA) influences gastrointestinal (GI) tract motility are incompletely understood and complicated by tissue-and species-specific differences in dopaminergic function. To improve the understanding of DA action on GI motility, we used an organ tissue bath system to characterize motor function of distal colonic smooth muscle segments from wild-type and DA transporter knockout (DAT Ϫ/Ϫ) mice. In wild-type mice, combined blockade of D 1 and D 2 receptors resulted in significant increases in tone (62 Ϯ 9%), amplitude of spontaneous phasic contractions (167 Ϯ 24%), and electric field stimulation (EFS)-induced (40 Ϯ 8%) contractions, suggesting that endogenous DA is inhibitory to mouse distal colonic motility. The amplitudes of spontaneous phasic and EFS-induced contractions were lower in DAT Ϫ/Ϫ mice relative to wild-type mice. These differences were eliminated by combined D 1 and D 2 receptor blockade, indicating that the inhibitory effects of DA on distal colonic motility are potentiated in DAT Ϫ/Ϫ mice. Motility index was decreased but spontaneous phasic contraction frequency was enhanced in DAT Ϫ/Ϫ mice relative to wild-type mice. The fact that spontaneous phasic and EFS-induced contractile activity were altered by the lack of the DA transporter suggests an important role for endogenous DA in modulating motility of mouse distal colon. transgenic mice; motility index; dopamine receptor antagonists; electric field stimulation; peripheral hyperdopaminergia GASTROINTESTINAL (GI) motility is modulated by a complex system of intrinsic and extrinsic nerves, circulating hormones, and locally produced mediators. One such modulator is dopamine (DA). A description of the effect of DA on GI motility is complicated for three main reasons. First, DA can produce both inhibitory and excitatory effects on GI motility (reviewed in Ref. 27). Generally, the excitatory response, which is mediated by D 2 or presynaptic receptors, occurs at a lower agonist concentration than the inhibitory response, which is mediated by D 1 or postsynaptic receptors. Second, the mechanism of DA action and location of DA receptors are controversial. For example, studies using guinea pig stomach and rabbit ileum suggest that DA-mediated inhibition of GI motility occurs through modulation of the enteric nervous system (9, 25), whereas reports using gastric tissue from opossum indicate direct DA effects mediated by DA receptors on smooth muscle cells (3, 22) . Third, conclusions regarding the role of DA in modulating GI tract motility have primarily been reached using pharmacological techniques, interpretation of which is confounded by the ability of DA agonists to activate adrenergic receptors (reviewed in Ref. 27). Thus more research is required to improve our understanding of DA-mediated regulation of GI motility.
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To better understand the role that DA plays in regulating GI motility, we characterized DA-mediated regulation of distal colonic motility in wild-type mice and in mice lacking the DA transporter (DAT Ϫ/Ϫ mice). The DA transporter (DAT) regulates the concentration of DA in the synaptic cleft by rapidly removing the released neurotransmitter from the extracellular space (reviewed in Ref. 6) . Recently, there has also been evidence demonstrating the presence of the DA transporter in DA-producing endocrine cells of the gut (11) . Despite diminished intraneuronal levels of DA, extracellular DA levels are elevated and DAT Ϫ/Ϫ mice display a central hyperdopaminergic phenotype characterized by increased locomotion, neuroendocrine dysfunction, and dwarfism (8) . We explored whether DAT Ϫ/Ϫ mice may also exhibit a hyperdopaminergic phenotype in peripheral tissue such as the distal colon. In the present report, the effects of DA and DA receptor antagonists on colonic contractility were evaluated in wild-type and DAT Ϫ/Ϫ mice.
Our results demonstrate that motility of the mouse distal colon is under basal inhibitory control by DA and that this effect is potentiated in mice lacking the DAT. This hyperdopaminergic phenotype associated with DAT Ϫ/Ϫ mice is characterized by an impaired ability to generate contractile force coupled with an increased frequency of spontaneous phasic contractions. The DAT Ϫ/Ϫ mouse could be an important model for further characterization of the role of DA in regulating murine GI physiology, since DA modulates not only GI motility but also GI secretion (19) . Moreover, DAT Ϫ/Ϫ mice may be useful for the study of other peripheral systems under DA regulation, such as the vasculature, kidneys, and immune system.
METHODS

General Methods
DAT knockout mice were created through genetic deletion of the DAT by homologous recombination (8) . Wild-type and homozygous DAT Ϫ/Ϫ mice were derived from crossing heterozygous DAT C57BL6/129SvJ animals. Mice were housed in an animal care facility at a temperature of 23°C on a light-dark cycle of 12:12 h and were caged with approximately three littermates of the same sex, having free access to food and water. Animal care was in accordance with institutional guidelines. Mice 12-20 wk of age (mean 16 wk) were killed by CO 2 inhalation, and the GI tract, from esophagus to distal colon, was removed and placed in Krebs solution. A distal colon section (ϳ12 mm ϫ 2 mm) was suspended along the longitudinal axis with surgical suture (4-0 silk) between platinum ring electrodes. The tissue, placed under an initial load of 0. Distal colon preparations were allowed to equilibrate in Krebs solution for at least 60 min before being adjusted to optimal length. The mechanical activity of the longitudinal muscle was measured isometrically with a calibrated force displacement transducer (Radnoti) and acquired using a computer data acquisition program (CODAS, DATAQ). Acquired data was analyzed using peak detection software, and data were imported into a spreadsheet for calculation of all tension parameters.
A Grass S88 stimulator was used to produce electric field stimulation (EFS) of tissues by passing current pulses between ring electrodes. In all experiments, pulses of 0.1-ms duration, 40 V, and 5 Hz were applied for 10 s. These stimulus parameters were chosen on the basis of preliminary studies that demonstrated maximal contractile tension with little or no direct effect on smooth muscle, as assessed by the ability of 1 m TTX to abolish the response.
Experimental Protocols
Dose response to DA. Increasing doses of DA were added, in half-log increments, to the organ tissue bath. With each new addition of DA, tissues were allowed to equilibrate for 2 min before EFS.
Effect of D 1 and D 2 receptor blockade. For antagonist doseresponse protocols, tissues were incubated with 10 M sulpiride and Sch-23390 for 8 min before EFS or addition of DA. If tissues were used for more than one protocol, a 30-min washout period was conducted between protocols.
Motility index. We used a modified equation to calculate motility index (2, 14) . The motility index of phasic activity was calculated as the total area under the tension curve minus the area due to smooth muscle tone. Smooth muscle tone was calculated as the tension measured when no spontaneous phasic contraction was in progress. For each 2-min period (over the 30-min interval), each valley (minimum tension between spontaneous phasic contractions) was marked, sorted, and averaged. Each 2-min average tension was multiplied by 120 s, and these products were summed to give the area due to smooth muscle tone. Data used to calculate motility index were recorded before addition of test agents.
KCl depolarization. KCl was added to the Krebs solution with equimolar replacement of NaCl (18) .
HPLC assessment of tissue content of DA. Dissected GI tissue was homogenized in 5 vol of 0.1 M HClO 4 containing 50 ng/ml 3,4-dihydroxybenzylamine as an internal standard. Homogenates were centrifuged for 10 min at 10,000 g. Supernatants were filtered through a 0.22-m filter and analyzed for levels of DA using HPLC with electrochemical detection as described previously (26) . Monoamines and metabolites were separated on a microbore reverse-phase column (C-18, 5 m, 1 ϫ 150 mm; Unijet, Bioanalytical Systems) with a mobile phase consisting of 0.03 M citratephosphate buffer with 2.1 mM octyl sodium sulfate, 0.1 mM EDTA, 10 mM NaCl, and 17% methanol (pH 3.6) at a flow rate of 90 l/min and detected by a 3-mm glass carbon electrode (Unijet) set at ϩ0.65 V. The volume of injection was 5 l.
Drugs and Chemicals
DA, sulpiride (D 2 receptor antagonist), and Sch-23390 (D 1 receptor antagonist) were purchased from Research Biochemicals. Carbachol and sodium nitroprusside (SNP) were purchased from Sigma Chemicals. Other chemicals used were of reagent grade.
Calculations and Statistics
The maximal contractile response to 100 M carbachol was measured in each experiment. The amplitude of EFSinduced or spontaneous phasic contractions was calculated as the difference between peak tension developed and the average control baseline tension. Statistical analyses were carried out using the computer software package GraphPad Prism. To determine differences between mouse genotypes, a Student's two-tailed t-test was used. To determine the effect of treatment within a mouse genotype, a Student's two-tailed t-test for repeated measures was used. Results were considered significantly different if P Ͻ 0.05.
RESULTS
Maximal Contractile Response to Carbachol
The maximal contractile tonic tension generated in response to 100 M carbachol was significantly less in DAT Ϫ/Ϫ mice (2,908 Ϯ 141 mg) relative to wild-type mice (3,492 Ϯ 140 mg) (P ϭ 0.03).
Effect of DA on EFS-Induced Contractions in Wild-Type Mouse Distal Colon
To assess the effect of DA on distal colonic contractions, the amplitude of EFS-induced contraction was measured in the presence of increasing concentrations of DA. (Fig. 2) . These data suggest that EFS activates the release of DA, which acts at DA receptors to inhibit the amplitude of the resultant contraction. Thus DA, whether exogenously applied or endogenously released, acts at DA receptors to inhibit the amplitude of an EFS-induced contraction. Although EFS mimics a physiological event (depolarization of neurons), this does not necessarily implicate DA in the regulation of intrinsic distal colonic motility.
Effect of DA on the Motility of Wild-Type Mouse Distal Colon
To determine whether DA participates in the regulation of intrinsic distal colonic motility, we measured tonic and spontaneous phasic contractile activity before and after D 1 and D 2 receptor blockade. A representative recording (Fig. 3A) shows that smooth muscle tone and spontaneous phasic contraction amplitude are enhanced following D 1 and D 2 receptor blockade. Figure 3B illustrates the average effect of D 1 and D 2 receptor blockade on basal smooth muscle tone and spontaneous phasic contractions. Thus spontaneous phasic motility and tone of mouse distal colon are under basal inhibitory control by a DA-mediated system.
Tissue DA Concentration in Mouse Distal Colon
Tissue DA concentration primarily reflects intracellular DA stores (reviewed in Ref. 7) and was found to be significantly reduced in the distal and proximal colon of DAT Ϫ/Ϫ mice (Fig. 4) . Previous studies have shown similar depletion of DA stores in central neurons of DAT Ϫ/Ϫ mice (15) . These data support, albeit indirectly, the importance of DAT-related processes in these tissues and suggest that in DAT Ϫ/Ϫ mice DA is not efficiently cleared from the synaptic cleft, which may result in a hyperdopaminergic phenotype (6) .
Characterization of Distal Colonic Motility in the DAT Ϫ/Ϫ Mouse
We hypothesized that the distal colon of DAT Ϫ/Ϫ mice would display functional hyperdopaminergia and that this condition would therefore manifest as decreased smooth muscle tone and diminished amplitude of spontaneous phasic and EFS-induced contractions relative to wild-type mice. Furthermore, we postulated that if these differences could be eliminated by D 1 and D 2 receptor blockade then this would provide further evidence that contractile differences observed between wild-type and DAT Ϫ/Ϫ mice are due to the pharmacological action of the enhanced dopaminergic condition. To assess the magnitude of distal colonic smooth muscle tone, we administered 100 M SNP, a dose that we determined elicits maximal relaxation. SNP caused a significantly smaller relaxation in DAT Ϫ/Ϫ mice (366 Ϯ 48 mg) than wild-type mice (499 Ϯ 34). Furthermore, the amplitude of spontaneous phasic and EFS-induced contractions was significantly less in DAT Ϫ/Ϫ mice relative to wild-type mice (Fig. 5, A  and B, left) . Since DA inhibits the amplitude of spontaneous phasic and EFS-induced contractions in wild-type mice, these data are consistent with the hypothesis that DAT Ϫ/Ϫ mice display decreased distal colonic motility secondary to a state of hyperdopaminergia. The observation that differences in contraction amplitude were abrogated by D 1 and D 2 receptor blockade (Fig. 5, A and B, right) supports the notion that DA is responsible for the reduced contraction amplitude observed in DAT Ϫ/Ϫ mice.
Motility Index of Wild-Type and DAT Ϫ/Ϫ Mouse Distal Colon
To further evaluate the role of DA on GI motility, the motility index was measured in DAT Ϫ/Ϫ and wildtype mice. In DAT Ϫ/Ϫ mice, the average motility index (area under the tension curve minus the area due to basal tone) was significantly diminished relative to wild-type mice (Fig. 6) . To determine the principal parameter responsible for the decreased motility index in DAT Ϫ/Ϫ mice, we calculated spontaneous phasic contraction frequency and amplitude. Although spontaneous phasic contractions were much more frequent in DAT Ϫ/Ϫ mice than in wild-type mice (Fig. 7A) , the distribution of the amplitude of these contractions is heavily weighted toward those of smaller amplitude (Fig. 7B) .
To determine whether the difference in phasic contraction frequency was a function of a more depolarized membrane potential in DAT Ϫ/Ϫ mice, tissues were incubated in modified Krebs solution containing increasing concentrations of K ϩ .
According to Mangel et al. (17) a greater increase in extracellular K
ϩ is required to depolarize cells with an already depolarized resting membrane potential. In wild-type mice, 10-20 mM KCl significantly increased spontaneous phasic contraction frequency relative to control. These concentrations of KCl had no significant effect on spontaneous phasic contraction frequency in DAT Ϫ/Ϫ mice, suggesting that the resting membrane potential in DAT Ϫ/Ϫ distal colon is depolarized relative to wild-type mice (Fig. 7C) . In both wild-type and DAT Ϫ/Ϫ mice, incubation with KCl concentrations Ͼ20 mM resulted in decreased spontaneous phasic contraction frequency (Fig. 7C) .
DISCUSSION
In this study we demonstrated that DA-mediated inhibitory input is tonically supplied to the mouse colon. Furthermore, we showed that this inhibition is enhanced in the DAT Ϫ/Ϫ mouse, which is consistent with a peripheral hyperdopaminergic phenotype. Finally, these studies provide evidence that endogenously released DA inhibits both spontaneous phasic and EFS-induced contraction amplitude.
Little is known about the role of DA in regulating GI motility in the mouse. Eaker et al. (4) provided evidence indicating the presence of DA-containing neurons in the myenteric plexus of the GI tract of mice; however, an earlier report by Fontaine et al. (5) reported that DA receptors were not present in the mouse colon. Our findings indicate a role for DA in regulating murine distal colon motility and highlight the importance of the DA transporter for this regulation.
This study demonstrates that DA inhibits distal colonic tone and the amplitude of spontaneous phasic and EFS-induced contractions in wild-type mice. This inhibitory effect of DA is more pronounced in DAT Ϫ/Ϫ mice, suggesting that DAT Ϫ/Ϫ mice display peripheral hyperdopaminergia. This "functional" excess of DA in the periphery is consistent with that previously described for the central nervous system of DAT Ϫ/Ϫ mice (6, 8) . In central neurons, one of the hallmarks of this hyperdopaminergic phenotype is depletion of DA stores. We also found decreased DA stores in DAT Ϫ/Ϫ mouse distal colon.
In distal colonic smooth muscles, both spontaneous phasic and tonic components of tension are present (reviewed in Ref. 16 ). Spontaneous rhythmic or "phasic" smooth muscle cell contractions are initiated by slow waves. These slow waves depolarize the smooth muscle cell membrane potential, leading to opening DAT Ϫ/Ϫ mice display decreased distal colonic smooth muscle tone. We used SNP, a nitric oxide (NO) donor, to relax distal colonic smooth muscle and observed that DAT Ϫ/Ϫ mice relax less than wild-type mice. There are at least two possible explanations for these results. First, according to Tare et al. (24) , NO has a reduced capacity to relax smooth muscle when membrane potential is depolarized. As mentioned above, the results of the KCl depolarization protocol could suggest that membrane potential is depolarized in DAT Ϫ/Ϫ mice relative to wild-type mice. Second, the reduced tone observed in DAT Ϫ/Ϫ mice could be a result of interactions of DA with other steps in the process of pharmacomechanical coupling. For example, stimulation of G protein-coupled receptors, such as DA receptors, leads to activation of second messengerdependent protein kinases (21) . These kinases can affect smooth muscle tone by regulating voltage-sensi- Carbachol induces distal colonic smooth muscle contraction. In the present study, the amplitude of carbachol-induced contraction was significantly reduced in DAT Ϫ/Ϫ mice relative to wild-type mice. Although this measure can be used to normalize differences in tissue cross-sectional area, values reported herein were not normalized. The data in Fig.  5 show that a reduction in cross-sectional area of the smooth muscle wall is not responsible for the reduced contraction amplitude observed in DAT Ϫ/Ϫ mice. Rather, the results suggest that the tension developed by DAT Ϫ/Ϫ mouse colon is similar to that of wild-type mice when D 1 and D 2 receptors are blocked, suggesting that DA is responsible for the reduced capacity to develop tension in DAT Ϫ/Ϫ mice.
Although the mechanism of action of DA has not been fully characterized in the GI tract, it is generally accepted that in gut tissue D 1 and D 2 receptors are the primary functional subtypes of DA receptors (reviewed in Ref. 27 ). D 1 receptors are mainly located postsynaptically, whereas D 2 receptors are located pre-and postsynaptically. The use of receptor antagonists to discriminate DA effects from the effects of other catecholamines is not trivial and has led to some confusion regarding the physiological role of DA. There is some promiscuity among dopaminergic and adrenergic agonists/antagonists (reviewed in Ref. 27 ). Being aware of the controversy surrounding selectivity, or lack thereof, of DA receptor antagonists, we carefully chose and used agents that would simplify interpreta- tion of the data. Sch-23390 is a potent and selective D 1 receptor antagonist that has very little effect on other receptors (12) . Although D 2 receptors and ␣ 2 -adrenergic receptors are functionally similar, sulpiride (a D 2 receptor antagonist) has a 200-fold greater affinity for D 2 receptors than ␣ 2 -adrenergic receptors (reviewed in Ref. 13 ). Thus Sch-23390 and sulpiride were used because they exhibit minimal nonspecific effects on other receptor systems.
Despite this selectivity, the relatively unimpressive effect of D 1 and D 2 blockade on the DA dose-response curve (Fig. 1) may lead one to conclude that Sch-23390 and sulpiride are poor receptor inhibitors or have nonspecific excitatory effects. The more likely explanation for the modest shift in the DA dose-response curve is nonspecific effects of DA at adrenergic receptors. Exogenously administered DA is known to activate adrenergic receptors, and if some fraction of the DAmediated inhibition of EFS-induced contraction amplitude was mediated through adrenergic receptors, it would not be inhibited by the DA receptor antagonists used.
The data presented herein highlight the difficulty in trying to determine peripheral DA function by the addition of exogenous DA or its analogs. Through neuronal or autocrine release (4, 11, 20, 23) , a high concentration of DA localizes at DA receptors in the GI tract, resulting in altered motility or secretion. This localized release of DA cannot be mimicked by exogenous addition of DA, which would have an ubiquitous distribution throughout the tissue. Thus exogenously administered DA may be of sufficient concentration to activate adrenergic receptors. Therefore, addition of exogenous DA is a less than optimal method of mimicking the physiological effects of DA in the GI tract.
The difficulties associated with adding exogenous DA to assess physiological function emphasize the importance of an animal model, such as the DAT Ϫ/Ϫ mouse, which is characterized by excessive endogenous DA. This mouse model provides an opportunity to study peripheral DA function simply by comparing the physiology of DAT Ϫ/Ϫ mice to wild-type mice.
Characterization of mouse physiology, and its relevance to that of humans, is of increasing importance given the current trend of linking genes to function. The DAT Ϫ/Ϫ mouse could be a valuable tool used to delineate the mechanisms of DA action on GI tract motility. Such studies may provide information useful in the delineation of therapeutic targets. Furthermore, studies investigating the role of DA in other peripheral systems may find the DAT Ϫ/Ϫ mouse to be an attractive model, since peripheral DA-mediated physiological effects can be revealed in these mice without exogenous administration of DA.
